Merve Saylam
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Merve Saylam has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Ayse Hande Tarikogullari
Ege University Faculty of Pharmacy, Department of Pharmaceutical Chemistry, İzmir, Türkiye
4 shared publications - Sinem Yilmaz
Department of Biotechnology, Graduate School of Natural and Applied Sciences, Ege University
3 shared publications - Huseyin Istanbullu
İzmir Katip Çelebi University, Turkey
2 shared publications - Petek Ballar Kirmizibayrak
Department of Biochemistry, Faculty of Pharmacy, Ege University, İzmir, Türkiye
2 shared publications - Sulunay Parlar
Ege University, Faculty of Pharmacy, Department of Pharmaceutical Chemistry
2 shared publications - Vildan Alptüzün
Department of Pharmaceutical Chemistry Faculty of Pharmacy, Ege University Izmir Turkey
2 shared publications
Latest Publications
- Open Access
- 9 October 2024
- Published by Elsevier in European Journal of Medicinal Chemistry Reports
- Vol. 12
Biological properties and in silico studies of thiazolopyrimidine derivatives active against visceral and cutaneous Leishmania spp. amastigote forms
- 9 October 2024
- Published by Elsevier in European Journal of Medicinal Chemistry Reports
- Vol. 12
Open AccessBiological properties and in silico studies of thiazolopyrimidine derivatives active against visceral and cutaneous Leishmania spp. amastigote forms
- Open Access
- 13 February 2024
- Published by Galenos Yayinevi in Turkish Journal of Pharmaceutical Sciences
- Vol. 22 (1) , 1-9
3-(1H-pyrazole-1-yl/1H-1,2,4-triazole-1-yl)-N-propananilide derivatives: Design, Synthesis and Neuroprotectivity Potential Against 6-OHDA Induced Neurotoxicity Model
Excessive amounts of neuroapoptosis are the underlying cause of neurodegenerative diseases. Bax is a pro-apoptotic member of the B-cell lymphoma-2 family that activates caspases which are the members of the cysteine protease family that play a significant role in the initiation and execution phases of apoptosis. The aim of this study was to design and synthesize a group of N-propananilide derivatives bearing pyrazole or 1,2,4-triazole ring were designed and synthesized to analyze the neuroprotectivity potential against 6-hydroxy-dopamine (6-OHDA). Four compounds possessed protectivity at lower doses were subjected to further studies on caspase-3 and Bax pathway. Designed compounds were synthesized by reacting 1H-pyrazole or 1H-1,2,4-triazole with propananilide intermediates in Dimethylformamide. The neuroprotective activity of the title compounds was analyzed against 6-OHDA-6-OHDA-induced neurotoxicity model. Then, caspase-3 and Bax levels were determined for the selected compounds by Western blot study. All twelve 3-(1H-pyrazole-1-yl/1H-1,2,4-triazole-1-yl)-N-propananilide derivatives possessed neuroprotectivity against the 6-OHDA-induced neurotoxicity model (p≤0.05, **p≤0.001, ***p≤0.005). Compounds 7, 10, 11, and 12 were found to be more active at lower doses. They were subjected to further studies and the results revealed that their protecting activity arose from the decreasing levels of Bax, one of the pro-apoptotic proteins, and c expression levels and caspase-3 proteins. All designed and synthesized derivatives possessed neuroprotectivity against 6-OHDA-induced neurotoxicity in the SH-SY5Y cell line and compounds 7, 10, 11, and 12 revealed that their neuroprotectivity originated from the decreasing Bax expression levels and caspase-3 activation.
- 13 February 2024
- Published by Galenos Yayinevi in Turkish Journal of Pharmaceutical Sciences
- Vol. 22 (1) , 1-9
Open Access3-(1H-pyrazole-1-yl/1H-1,2,4-triazole-1-yl)-N-propananilide derivatives: Design, Synthesis and Neuroprotectivity Potential Against 6-OHDA Induced Neurotoxicity Model
Excessive amounts of neuroapoptosis are the underlying cause of neurodegenerative diseases. Bax is a pro-apoptotic member of the B-cell lymphoma-2 family that activates caspases which are the members of the cysteine protease family that play a significant role in the initiation and execution phases of apoptosis. The aim of this study was to design and synthesize a group of N-propananilide derivatives bearing pyrazole or 1,2,4-triazole ring were designed and synthesized to analyze the neuroprotectivity potential against 6-hydroxy-dopamine (6-OHDA). Four compounds possessed protectivity at lower doses were subjected to further studies on caspase-3 and Bax pathway. Designed compounds were synthesized by reacting 1H-pyrazole or 1H-1,2,4-triazole with propananilide intermediates in Dimethylformamide. The neuroprotective activity of the title compounds was analyzed against 6-OHDA-6-OHDA-induced neurotoxicity model. Then, caspase-3 and Bax levels were determined for the selected compounds by Western blot study. All twelve 3-(1H-pyrazole-1-yl/1H-1,2,4-triazole-1-yl)-N-propananilide derivatives possessed neuroprotectivity against the 6-OHDA-induced neurotoxicity model (p≤0.05, **p≤0.001, ***p≤0.005). Compounds 7, 10, 11, and 12 were found to be more active at lower doses. They were subjected to further studies and the results revealed that their protecting activity arose from the decreasing levels of Bax, one of the pro-apoptotic proteins, and c expression levels and caspase-3 proteins. All designed and synthesized derivatives possessed neuroprotectivity against 6-OHDA-induced neurotoxicity in the SH-SY5Y cell line and compounds 7, 10, 11, and 12 revealed that their neuroprotectivity originated from the decreasing Bax expression levels and caspase-3 activation.
- 28 November 2023
- Published by Istanbul University in İstanbul Journal of Pharmacy
- Vol. 53 (3) , 287-293
The investigation of drug repurposing for HDAC1 inhibitory effects by in silico and in vitro methods
- 28 November 2023
- Published by Istanbul University in İstanbul Journal of Pharmacy
- Vol. 53 (3) , 287-293
The investigation of drug repurposing for HDAC1 inhibitory effects by in silico and in vitro methods
- 6 January 2022
- Published by ACG Publications in Bioorganic and Medicinal Chemistry Reports
- Vol. 4 (2) , 1-5
Neuroprotective activity studies of some phenylacetamide derivatives bearing 1H-pyrazole or 1H-1,2,4-triazole
Neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and Huntington’s diseases are one of the most studied diseases in health sciences. Although each of them has their own mechanisms and outcomes, they share molecular mechanisms like oxidative stress which plays the key role in neurodegeneration. Therefore, alleviating the oxidative stress and improving the antioxidant defense capacity of the brain tissue helps to reduce the progression of neurotoxicity in neurodegenerative diseases including the Alzheimer’s disease. In this regard, we have studied the neuroprotective activity of the compounds that were determined as the most active derivatives against AChE enzyme in our previous study. The results revealed that Compounds 3 and 4 restore the cell viability especially at lower doses, hence, these two molecules may be a promising lead for further studies with their neuroprotectivity potential and AChE inhibitory activity.
- 6 January 2022
- Published by ACG Publications in Bioorganic and Medicinal Chemistry Reports
- Vol. 4 (2) , 1-5
Neuroprotective activity studies of some phenylacetamide derivatives bearing 1H-pyrazole or 1H-1,2,4-triazole
Neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and Huntington’s diseases are one of the most studied diseases in health sciences. Although each of them has their own mechanisms and outcomes, they share molecular mechanisms like oxidative stress which plays the key role in neurodegeneration. Therefore, alleviating the oxidative stress and improving the antioxidant defense capacity of the brain tissue helps to reduce the progression of neurotoxicity in neurodegenerative diseases including the Alzheimer’s disease. In this regard, we have studied the neuroprotective activity of the compounds that were determined as the most active derivatives against AChE enzyme in our previous study. The results revealed that Compounds 3 and 4 restore the cell viability especially at lower doses, hence, these two molecules may be a promising lead for further studies with their neuroprotectivity potential and AChE inhibitory activity.
- 1 January 2021
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 209, 112890
Design, synthesis and biological evaluation of novel naphthoquinone-4-aminobenzensulfonamide/carboxamide derivatives as proteasome inhibitors
- 1 January 2021
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 209, 112890
Design, synthesis and biological evaluation of novel naphthoquinone-4-aminobenzensulfonamide/carboxamide derivatives as proteasome inhibitors
- Open Access
- 27 September 2019
- Published by International Union of Crystallography (IUCr) in Acta Crystallographica Section E Crystallographic Communications
- Vol. 75 (10) , 1531-1535
Crystal structure and Hirshfeld surface analysis of 2-[(1,3-benzoxazol-2-yl)sulfanyl]-N-(2-methoxyphenyl)acetamide
In the title compound, C16H14N2O3S, the 1,3-benzoxazole ring system is essentially planar (r.m.s deviation = 0.004 Å) and makes a dihedral angle of 66.16 (17)° with the benzene ring of the methoxyphenyl group. Two intramolecular N—H...O and N—H...N hydrogen bonds occur, forming S(5) and S(7) ring motifs, respectively. In the crystal, pairs of C—H...O hydrogen bonds link the molecules into inversion dimers with R 2 2(14) ring motifs, stacked along the b-axis direction. The inversion dimers are linked by C—H...π and π–π-stacking interactions [centroid-to-centroid distances = 3.631 (2) and 3.631 (2) Å], forming a three-dimensional network. Two-dimensional fingerprint plots associated with the Hirshfeld surface show that the largest contributions to the crystal packing come from H...H (39.3%), C...H/H...C (18.0%), O...H/H...O (15.6) and S...H/H...S (10.2%) interactions.
- 27 September 2019
- Published by International Union of Crystallography (IUCr) in Acta Crystallographica Section E Crystallographic Communications
- Vol. 75 (10) , 1531-1535
Open AccessCrystal structure and Hirshfeld surface analysis of 2-[(1,3-benzoxazol-2-yl)sulfanyl]-N-(2-methoxyphenyl)acetamide
In the title compound, C16H14N2O3S, the 1,3-benzoxazole ring system is essentially planar (r.m.s deviation = 0.004 Å) and makes a dihedral angle of 66.16 (17)° with the benzene ring of the methoxyphenyl group. Two intramolecular N—H...O and N—H...N hydrogen bonds occur, forming S(5) and S(7) ring motifs, respectively. In the crystal, pairs of C—H...O hydrogen bonds link the molecules into inversion dimers with R 2 2(14) ring motifs, stacked along the b-axis direction. The inversion dimers are linked by C—H...π and π–π-stacking interactions [centroid-to-centroid distances = 3.631 (2) and 3.631 (2) Å], forming a three-dimensional network. Two-dimensional fingerprint plots associated with the Hirshfeld surface show that the largest contributions to the crystal packing come from H...H (39.3%), C...H/H...C (18.0%), O...H/H...O (15.6) and S...H/H...S (10.2%) interactions.
- Open Access
- 1 October 2015
- Published by Marmara University in Marmara Pharmaceutical Journal
- Vol. 20 (1) , 21-27-21
Synthesis and cholinesterase inhibitory activity of some phenylacetamide derivatives bearing 1H-pyrazole and 1H-1,2,4-triazole
Synthesis and cholinesterase inhibitory activity of some phenylacetamide derivatives bearing 1H-pyrazole and 1H-1,2,4-triazole
- 1 October 2015
- Published by Marmara University in Marmara Pharmaceutical Journal
- Vol. 20 (1) , 21-27-21
Open AccessSynthesis and cholinesterase inhibitory activity of some phenylacetamide derivatives bearing 1H-pyrazole and 1H-1,2,4-triazole
Synthesis and cholinesterase inhibitory activity of some phenylacetamide derivatives bearing 1H-pyrazole and 1H-1,2,4-triazole